Strategic Wealth Partners’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.9M | Buy |
+169,881
| New | +$11.9M | 0.93% | 25 |
|
|
2024
Q4 | $11.8M | Buy |
158,945
+61,259
| +63% | +$4.56M | 0.98% | 26 |
|
|
2024
Q3 | $7.61M | Buy |
97,686
+4,313
| +5% | +$336K | 0.73% | 45 |
|
|
2024
Q2 | $7.28M | Buy |
93,373
+4,158
| +5% | +$324K | 0.76% | 39 |
|
|
2024
Q1 | $6.04M | Buy |
89,215
+9,181
| +11% | +$622K | 0.66% | 52 |
|
|
2023
Q4 | $5.39M | Buy |
80,034
+22,700
| +40% | +$1.53M | 0.66% | 48 |
|
|
2023
Q3 | $3.88M | Buy |
57,334
+22,373
| +64% | +$1.52M | 0.51% | 53 |
|
|
2023
Q2 | $2.5M | Sell |
34,961
-171
| -0.5% | -$12.2K | 0.32% | 94 |
|
|
2023
Q1 | $2.44M | Buy |
35,132
+2,422
| +7% | +$168K | 0.37% | 78 |
|
|
2022
Q4 | $2.22M | Buy |
32,710
+10,288
| +46% | +$698K | 0.41% | 76 |
|
|
2022
Q3 | $1.23M | Buy |
22,422
+1,418
| +7% | +$77.8K | 0.26% | 114 |
|
|
2022
Q2 | $1.39M | Buy |
21,004
+1,575
| +8% | +$104K | 0.3% | 101 |
|
|
2022
Q1 | $1.29M | Buy |
19,429
+2,981
| +18% | +$198K | 0.25% | 114 |
|
|
2021
Q4 | $958K | Buy |
16,448
+5,129
| +45% | +$299K | 0.18% | 144 |
|
|
2021
Q3 | $680K | Buy |
11,319
+135
| +1% | +$8.11K | 0.2% | 138 |
|
|
2021
Q2 | $670K | Buy |
11,184
+174
| +2% | +$10.4K | 0.22% | 119 |
|
|
2021
Q1 | $547K | Buy |
+11,010
| New | +$547K | 0.22% | 114 |
|
|
2019
Q2 | – | Sell |
-117
| Closed | -$5K | – | 733 |
|
|
2019
Q1 | $5K | Buy |
+117
| New | +$5K | ﹤0.01% | 622 |
|
|
2018
Q2 | – | Sell |
-427
| Closed | -$15K | – | 750 |
|
|
2018
Q1 | $15K | Buy |
427
+167
| +64% | +$5.87K | 0.01% | 428 |
|
|
2017
Q4 | $9K | Buy |
+260
| New | +$9K | 0.01% | 547 |
|